RecruitingNCT07643610

BEAT-SHOCK Registry

BEAT-SHOCK (Basel Evaluation of Acute Therapy in Cardiogenic SHOCK) Registry

Sponsor

University Hospital, Basel, Switzerland

Enrollment

8,000 participants

Start Date

Oct 1, 2025

Study Type

OBSERVATIONAL

Conditions

Cardiogenic Shock Myocardial Infarction (MI)Acute Decompensated Heart Failure Fulminant Myocarditis Severe Valvular Disease Post-cardiotomy Perioperative Cardiogenic Shock

Summary

This regulation defines the purpose, the operational processes, and the organization of the registry BEAT-SHOCK (Basel Evaluation of Acute Therapy in cardiogenic SHOCK). It describes the requirements for collecting, storing, processing, managing and sharing health-related registry data.

Eligibility

Min Age: 18 Years

Inclusion Criteria12

Patients admitted with cardiogenic shock to the University hospital Basel (diagnosis at the time of admission) or development of cardiogenic shock during the hospital stay
Age ≥18 years
Provision of written ICF
Clinical diagnosis of cardiogenic shock.
impaired organ perfusion due to primary cardiac dysfunction,
persistent systolic blood pressure (SBP) <90 mmHg for ≥30 minutes, or the need for vasopressors, inotropes, or mechanical circulatory support (MCS) to maintain adequate perfusion and
evidence of systemic hypoperfusion with arterial lactate ≥2 mmol/L or venous lactate ≥3 mmol/l and ≥1 of the following:
Cold or clammy extremities
Altered mental status
Reduced urine output
Signs of volume overload or congestion (on clinical exam, imaging, or invasive monitoring)
Patients with normotensive cardiogenic shock (SBP ≥90 mmHg without vasopressors or MCS) may also be included if clear signs of hypoperfusion (arterial lactate ≥2 mmol/L or venous lactate ≥3 mmol/l) and cardiac dysfunction are present and alternative causes are excluded